Comments on: New Option for the Management of Acute Pain http://brainblogger.com/2008/12/13/new-option-for-the-management-of-acute-pain/ Topics from multidimensional biopsychosocial perspectives Mon, 21 May 2012 22:26:26 +0000 hourly 1 By: Andrew O'Sheahttp://brainblogger.com/2008/12/13/new-option-for-the-management-of-acute-pain/#comment-600824 Andrew O'Shea Fri, 02 Jul 2010 18:09:29 +0000 http://brainblogger.com/?p=1996#comment-600824 Two other studies also confirm results of previous studies about the efficacy of tapentadol in controlling pain. The most exciting thing about tapentadol is not its ability to control acute pain (which should be expected by an opioid pain reliever) but rather its reduced gastrointestinal (GI) side effects. Opiates and their derivatives are know for their GI discomforting side effects such as nausea and constipation. Tapentadol has shown to produce less GI discomfort for patients which is important for continuing with treatment. I liked the article. References: Clinical Therapeutics Volume 31, Issue 2, February 2009, Pages 260-271 \Current Medical Research and Opinion May 2009, Vol. 25, No. 5, Pages 1095-1104Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study* Two other studies also confirm results of previous studies about the efficacy of tapentadol in controlling pain. The most exciting thing about tapentadol is not its ability to control acute pain (which should be expected by an opioid pain reliever) but rather its reduced gastrointestinal (GI) side effects.
Opiates and their derivatives are know for their GI discomforting side effects such as nausea and constipation. Tapentadol has shown to produce less GI discomfort for patients which is important for continuing with treatment.
I liked the article.
References:
Clinical Therapeutics
Volume 31, Issue 2, February 2009, Pages 260-271
\Current Medical Research and Opinion
May 2009, Vol. 25, No. 5, Pages 1095-1104

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study*

]]>